Research Shows That Ketamine Delivers Quickly For Treatment-Resistant Depression

In the biggest clinical trial to date testing this drug, the anesthetic ketamine delivered big and quickly to patients with treatment-resistant depression.

Researchers from the Icahn School of Medicine at Mount Sinai carried out the study, testing the drug in patients with major depressive disorder. They found that not only was it effective, but it delivered results in one day – significantly shorter than conventional antidepressants, which often require more than a week to begin to work.

Investigators evaluated 72 people diagnosed with treatment-resistant depression (defined as depression that persists after at least two drug interventions). These patients were split into a treatment arm, which was administered a single IV infusion of ketamine for 40 minutes, and a placebo arm, which received midazolam, an anesthetic also but in a different class.

Ketamine appears to be a safe and effective treatment option

Interviews with patients began after 24 hours, and patients were re-interviewed after seven days. At the first interview, the response rate in the treatment arm was 63.8 percent, compared to 28 percent in the placebo arm.

A week later, the response rate to the ketamine arm was still higher, at 45.7 percent, compared to 18.2 percent in the placebo arm.

Lead author James Murrough, MD, assistant professor of psychiatry at Mount Sinai, said that using midazolam as an active placebo allowed us to independently assess the antidepressant benefit of ketamine, excluding any anesthetic effects. Ketamine continues to show significant promise as a new treatment option for patients with severe and refractory forms of depression.

Dr. Murrough added, "We found that ketamine was safe and well-tolerated and that patients who demonstrated a rapid antidepressant effect after starting ketamine were able to maintain the response throughout the course of the study."

While the results are promising, Murrough said that future studies will need to be larger and placebo-controlled in order to support these findings and determine both the safety and efficacy profile of ketamine as a treatment for depression.

The research was presented at the American Psychiatric Association meeting in San Francisco. The findings should be considered preliminary until published in a peer-reviewed journal.

Source: MNT
Photo: Px Here

Anxiety Support Groups

Latest Post by pessimisticnitrex Fri, 12/06/2019 - 12:09am
Comments: 0
Latest Post by pessimisticnitrex Fri, 12/06/2019 - 12:09am
Comments: 0
Latest Post by pessimisticnitrex Fri, 12/06/2019 - 12:09am
Comments: 0
Latest Post by patriciamartine4084 Thu, 12/05/2019 - 5:47pm
Comments: 0

More Articles

Monoamine Oxidase Inhibitors (MAOIs), like selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants (TCAs), are a class of...

Prayer for anxiety may help some with dealing with the disorder. Listed below are the anxiety prayers that personally help me. Whatever your faith...

Social anxiety disorder (SAD) can be a crippling condition that keeps you from living your life, but sometimes the prescription anxiety...

Dysthymia is a chronic depression that is less severe than major depression, but which can last for years at a time. While people with dysthymia...

Depression and anxiety are currently considered as separate disorders. Some people clearly have one or the other, but many people experience an...

More Articles

If you reach adolescence or adulthood with little or no self-confidence, what do you do? Faking it (confidence) until you make it is a stretch for...

While one might assume that children with extreme social anxiety are hyper-aware of other people's emotions, it turns out that the opposite is...

The antidepressant Nardil, in the class of antidepressants known as monoamine oxidase inhibitors (MAOIs), is also frequently prescribed as a...

Elavil (known generically as amitriptyline) is a tricyclic antidepressant that was approved by the FDA back in 1961 for treatment of major...

Around 40 million American adults suffer from some kind of anxiety disorder. While there are effective therapies and medications that make it...

Why is this medication prescribed?

Prozac or Fluoxetine is an antidepressant (mood elevator) and is used to treat depression, obsessive-...

Feelings of anxiety and stress cause a number of physical and chemical changes in the body, including the release of adrenaline and other hormones...

Everyone who lives with bothersome anxiety symptoms should have a pouch or pocket in their bag or backpack that is an emergency calm-kit.

...

According to the DSM-IV, people suffering from a medical condition should only be diagnosed with a social anxiety disorder (SAD) if the anxiety is...

When we purchase health insurance as a safety net for if we become ill or injured, we're usually thinking of physical ailments. But mental illness...

Anafranil is the brand name of the tricyclic antidepressant clomipramine. It is approved by the FDA to treat obsessive-compulsive disorder and is...

Social anxiety disorder, sometimes called social phobia, is a very common type of anxiety disorder that affects approximately 15 million adults in...

Getting over a great love can be devastating, but while you’re coping, life goes on. While controlling anxiety during the grieving process can be...

One thing to remember before a first date is that the overall quality of your life does not hinge on its success. If the date goes belly-up, you...

Death anxiety is the fear we experience when contemplating or facing our own mortality. Like much of our anxiety, it is an anticipation of pain...